UK Automated Microbiology Market--Growth Opportunities
DESCRIPTION
TABLE OF CONTENTS
RELATED REPORTS
SAMPLE REQUEST
REVIEWS
DESCRIPTION
New report is an analysis of the major business opportunities emerging in the automated microbiology market during the next five years. The report is available by section, and can be customized to specific information needs and budget. The report examines key trends in the UK automated microbiology market; reviews current and emerging assays; analyzes potential applications of innovative diagnostic technologies; forecasts volume and sales for molecular diagnostic, microbial identification, antibiotic susceptibility, blood culture, urine screening and immunodiagnostic procedures, as well as over 100 infectious disease tests by assay, application, market segment, profiles leading players and potential market entrants; and suggests alternative business expansion strategies for suppliers.
Rationale
The level of automation in the microbiology laboratory has been lagging behind that of other major clinical laboratory segments, such as chemistry and hematology. The slow acceptance of the technology is in part due to the complexity of developing automation suitable for microbiology tests.
The introduction of automated microbiology instrumentation has been delayed by a number of intrinsic and technical problems. The diffusion of automated microbiology systems, once the technology was developed, has not matched that of other automated laboratory technologies. The acquisition of automation in microbiology has been slowed by forces less easily identifiable than the effects of various reimbursement plans. Some laboratories still believe that current instrumentation is not the ultimate technology and expect better automation on the horizon.
The driving force behind the need for rapid reporting of microbiological test results is the clinical relevance in a time of financial austerity, a time when cost and health care effectiveness to the patient and diagnostician looms ever larger, and where after-the-fact results at high expense are coming under severe scrutiny worldwide.
This comprehensive report will assist diagnostics industry executives, as well as companies planning to diversify into the dynamic and rapidly expanding microbiology market, in evaluating emerging opportunities and developing effective business strategies.
Supplier Shares, Sales and Volume Forecasts
- Sales and market shares of major suppliers of microbiology products, by individual test.
- Five-year test volume and sales forecasts for over 100 microbiology assays.
- Test volume estimates by method (molecular, serology/immunodiagnostics, culture/microscopy).
UK Market Overview
- Review of the market dynamics, trends, structure, size, growth and major suppliers.
- Estimated universe of laboratories performing microbiology testing.
- Specimen, test volume and sales forecasts.
Business Opportunities and Strategic Recommendations
- Emerging opportunities for new analyzers, reagents kits, IT and other products with significant market appeal during the next five years.
- Design criteria for decentralized testing products.
- Alternative market penetration strategies.
- Potential market entry barriers and risks.
Specimen Types
- Urine
- Sterile Fluids: Blood, Serum, CSF
- Throat Swabs, Respiratory Secretions
- Genital Secretions
- Stool
- Abscess/Wound
- Sputum
- Saliva
Applications
-Microbial Identification
-Antibiotic Susceptibility
-Urine Screening
-Blood Cultures
Review of Major Automated Systems
- Review of major automated molecular diagnostic, multipurpose, specialized, microbial identification, antibiotic susceptibility, blood culture, urine screening, and immunodiagnostic analyzers marketed by Abbott, Halifax, BD, Beckman Coulter/Danaher, Biolog, bioMerieux, Bio-Rad, Cepheid, Curetis, GenMark, Hologic, HTG, Labsystems, Qiagen, Roche, Siemens Healthineers, Sy-Lab, Sysmex, Tecan, Thermo Fisher, Tosoh and other suppliers.
Infectious Diseases Analyzed in the Report
AIDS/HIV, Adenovirus, Aeromonads, Bartonella, Blastocystis Hominis, Campylobacter, Candida, Chancroid, Chlamydia, Clostridium, Coronavirus, Coxsackievirus, Cryptosporidium, Cyclospora, CMV, E. Coli, Echovirus, Encephalitis, Enterovirus, EBV, Giardia, Gonorrhea, Granuloma Inguinale, Hantavirus, H. Pylori, Hepatitis, Herpes Influenza, Legionella, Lyme Disease, Lymphogranuloma, Malaria, Measles, Meningitis, Microsporidium, Mononucleosis, Mumps, Mycoplasma, HPV, Parvovirus, Pneumonia, Polyomaviruses, Pseudomonas, Rabies, RSV, Rhinovirus, Rotavirus , Rubella, Salmonella, Septicemia, Shigella, Staphylococci, Streptococci, Syphilis, Toxoplasmosis, Trichomonas, TB, Vibrio, West Nile, Yersinia.
Technology Assessment
- Assessment of molecular diagnostic, monoclonal antibody, immunoassay, and other technologies and their potential applications for the microbiology market.
- Global listings of companies developing or marketing microbiology products by individual test.
Competitive Strategies
- Strategic assessments of major suppliers and start-up firms developing innovative technologies and products, including their sales,
product portfolios, marketing tactics, collaborative arrangements, and new products in R&D.
- The companies analyzed in the report include:
- Abbott Laboratories
- Agilent Technologies
- Beckman Coulter/Danaher
- bioMerieux
- Bio-Rad
- DiaSorin
- Eiken Chemical
- Fujifilm Wako
- Fujirebio
- Grifols
- Instrumentation Laboratory/Werfen
- Kyowa Medex
- OrthoQuidel
- PerkinElmer
- Quest Diagnostics
- Roche
- Siemens Healthineers
- Sysmex
- Thermo Fisher
- Tosoh
Rationale
The level of automation in the microbiology laboratory has been lagging behind that of other major clinical laboratory segments, such as chemistry and hematology. The slow acceptance of the technology is in part due to the complexity of developing automation suitable for microbiology tests.
The introduction of automated microbiology instrumentation has been delayed by a number of intrinsic and technical problems. The diffusion of automated microbiology systems, once the technology was developed, has not matched that of other automated laboratory technologies. The acquisition of automation in microbiology has been slowed by forces less easily identifiable than the effects of various reimbursement plans. Some laboratories still believe that current instrumentation is not the ultimate technology and expect better automation on the horizon.
The driving force behind the need for rapid reporting of microbiological test results is the clinical relevance in a time of financial austerity, a time when cost and health care effectiveness to the patient and diagnostician looms ever larger, and where after-the-fact results at high expense are coming under severe scrutiny worldwide.
This comprehensive report will assist diagnostics industry executives, as well as companies planning to diversify into the dynamic and rapidly expanding microbiology market, in evaluating emerging opportunities and developing effective business strategies.
Supplier Shares, Sales and Volume Forecasts
- Sales and market shares of major suppliers of microbiology products, by individual test.
- Five-year test volume and sales forecasts for over 100 microbiology assays.
- Test volume estimates by method (molecular, serology/immunodiagnostics, culture/microscopy).
UK Market Overview
- Review of the market dynamics, trends, structure, size, growth and major suppliers.
- Estimated universe of laboratories performing microbiology testing.
- Specimen, test volume and sales forecasts.
Business Opportunities and Strategic Recommendations
- Emerging opportunities for new analyzers, reagents kits, IT and other products with significant market appeal during the next five years.
- Design criteria for decentralized testing products.
- Alternative market penetration strategies.
- Potential market entry barriers and risks.
Specimen Types
- Urine
- Sterile Fluids: Blood, Serum, CSF
- Throat Swabs, Respiratory Secretions
- Genital Secretions
- Stool
- Abscess/Wound
- Sputum
- Saliva
Applications
-Microbial Identification
-Antibiotic Susceptibility
-Urine Screening
-Blood Cultures
Review of Major Automated Systems
- Review of major automated molecular diagnostic, multipurpose, specialized, microbial identification, antibiotic susceptibility, blood culture, urine screening, and immunodiagnostic analyzers marketed by Abbott, Halifax, BD, Beckman Coulter/Danaher, Biolog, bioMerieux, Bio-Rad, Cepheid, Curetis, GenMark, Hologic, HTG, Labsystems, Qiagen, Roche, Siemens Healthineers, Sy-Lab, Sysmex, Tecan, Thermo Fisher, Tosoh and other suppliers.
Infectious Diseases Analyzed in the Report
AIDS/HIV, Adenovirus, Aeromonads, Bartonella, Blastocystis Hominis, Campylobacter, Candida, Chancroid, Chlamydia, Clostridium, Coronavirus, Coxsackievirus, Cryptosporidium, Cyclospora, CMV, E. Coli, Echovirus, Encephalitis, Enterovirus, EBV, Giardia, Gonorrhea, Granuloma Inguinale, Hantavirus, H. Pylori, Hepatitis, Herpes Influenza, Legionella, Lyme Disease, Lymphogranuloma, Malaria, Measles, Meningitis, Microsporidium, Mononucleosis, Mumps, Mycoplasma, HPV, Parvovirus, Pneumonia, Polyomaviruses, Pseudomonas, Rabies, RSV, Rhinovirus, Rotavirus , Rubella, Salmonella, Septicemia, Shigella, Staphylococci, Streptococci, Syphilis, Toxoplasmosis, Trichomonas, TB, Vibrio, West Nile, Yersinia.
Technology Assessment
- Assessment of molecular diagnostic, monoclonal antibody, immunoassay, and other technologies and their potential applications for the microbiology market.
- Global listings of companies developing or marketing microbiology products by individual test.
Competitive Strategies
- Strategic assessments of major suppliers and start-up firms developing innovative technologies and products, including their sales,
product portfolios, marketing tactics, collaborative arrangements, and new products in R&D.
- The companies analyzed in the report include:
- Abbott Laboratories
- Agilent Technologies
- Beckman Coulter/Danaher
- bioMerieux
- Bio-Rad
- DiaSorin
- Eiken Chemical
- Fujifilm Wako
- Fujirebio
- Grifols
- Instrumentation Laboratory/Werfen
- Kyowa Medex
- OrthoQuidel
- PerkinElmer
- Quest Diagnostics
- Roche
- Siemens Healthineers
- Sysmex
- Thermo Fisher
- Tosoh
TABLE OF CONTENTS
I. Introduction
II. Automated Microbiology Market Business Environment
III. New Product Development Opportunities
IV. Design Criteria for Decentralized Testing Products
V. Alternative Market Penetration Strategies
VI. Potential Market Entry Barriers and Risks
VII. Market and Technology Overview
A. Introduction
1. Major Factors Affecting Market Penetration for Microbiology Instrumentation
2. Traditional Practices
3. Technological Challenges
4. Automation: Impact on the Microbiology Laboratory and the Patient
B. Major Specimen Types
1. Urine
2. Sterile Fluids: Blood, Serum, and CSF
3. Throat Swabs and Respiratory Secretions
4. Genital Secretions
5. Stool
6. Abscess/Wound
7. Sputum
8. Saliva
C. Test Applications
1. Microbial Identification
2. Antibiotic Susceptibility
3. Urine Screening
a. Photometry
b. Bioluminescence
c. Colorimetric Filtration
d. Enzymatic Detection
e. Optical Detection
4. Blood Cultures
Table of Contents
(continued)
D. Major Automated and Semi-automated Microbiology Systems
1. Multiple Purpose Microbiology Systems
2. Specialized Microbiology Systems
3. Molecular Diagnostic Systems
4. Immunodiagnostic Systems
E. Emerging Diagnostic Technologies
1. Molecular Diagnostics (Amplification Methods, Sequencing, Microarrays/Biochips)
a. DNA Sequencing
b. DNA and RNA Probe Technologies
c. Detection Technologies
d. Biochips: Genosensors, Microarrays, Labs-on-the-Chip
2. Monoclonal Antibodies
3. Immunoassays
4. Differential Light Scattering
5. Information Technology
6. Artificial Intelligence
7. Liposomes
8. Flow Cytometry
9. Chromatography
10. Diagnostic Imaging
11. Gel Microdroplets
12. Other
VIII. Country Analysis
A. Business Environment
B. Market Structure
C. Market Size, Growth and Major Supplier Sales and Market Shares
IX. Competitive
Assessments
- Abbott Laboratories
- Agilent Technologies
- Beckman Coulter/Danaher
- bioMerieux
- Bio-Rad
- DiaSorin
- Eiken Chemical
- Fujifilm Wako
- Fujirebio
- Grifols
- Instrumentation Laboratory/Werfen
- Kyowa Medex
- OrthoQuidel
- PerkinElmer
- Quest Diagnostics
- Roche
- Siemens Healthineers
- Sysmex
- Thermo Fisher
- Tosoh
Major Companies Developing or Marketing Adenovirus Tests
Major Companies Developing or Marketing Bartonella Tests
Major Companies Developing or Marketing Campylobacter Tests
Major Companies Developing or Marketing Candida Tests
Major Companies Developing or Marketing Chlamydia Tests
Major Companies Developing or Marketing Clostridium Tests
Major Companies Developing or Marketing Coronavirus Tests
Major Companies Developing or Marketing Cryptosporidium Tests
Major Companies Developing or Marketing CMV Tests
Major Companies Developing or Marketing Echovirus Tests
Major Companies Developing or Marketing Enterovirus Tests
Major Companies Developing or Marketing EBV Tests
Major Companies Developing or Marketing Giardia Tests
Major Companies Developing or Marketing Gonorrhea Tests
Major Companies Developing or Marketing Hantavirus Tests
Major Companies Developing or Marketing Helicobacter Pylori Tests
Major Companies Developing or Marketing Hepatitis Tests
Major Companies Developing or Marketing Herpes Tests
Major Companies Developing or Marketing Influenza Tests
Major Companies Developing or Marketing Legionella Tests
Major Companies Developing or Marketing Lyme Disease Tests
Major Companies Developing or Marketing Lymphogranuloma Tests
Major Companies Developing or Marketing Malaria Tests
Major Companies Developing or Marketing Measles Tests
Major Companies Developing or Marketing Meningitis Tests
Major Companies Developing or Marketing Microsporidium Tests
Major Companies Developing or Marketing Mononucleosis Tests
Major Companies Developing or Marketing Mumps Tests
Major Companies Developing or Marketing Mycoplasma Tests
Major Companies Developing or Marketing Papilloma Virus Tests
Major Companies Developing or Marketing Parvovirus Tests
Major Companies Developing or Marketing Pneumonia Tests
Major Companies Developing or Marketing RSV Tests
Major Companies Developing or Marketing Rotavirus Tests
Major Companies Developing or Marketing Rubella Tests
Major Companies Developing or Marketing Salmonella Tests
Major Companies Developing or Marketing Septicemia Tests
Major Companies Developing or Marketing Shigella Tests
Major Companies Developing or Marketing Staphylococci Tests
Major Companies Developing or Marketing Streptococci Tests
Major Companies Developing or Marketing Syphilis Tests
Major Companies Developing or Marketing Toxoplasmosis Tests
Major Companies Developing or Marketing Trichomonas Tests
Major Companies Developing or Marketing Tuberculosis Tests
Major Companies Developing or Marketing West Nile Tests
Major Companies Developing or Marketing Yersinia Tests
U.K.
Laboratories Performing Microbiology Tests by Market Segment
U.K.
Hospital Laboratories Performing Microbiology Tests by Bed Size
U.K.
Commercial/Private Laboratories Performing Microbiology Tests
by Annual Test Volume
U.K.
All Market Segments Microbiology Specimen Volume
U.K.
Hospital Laboratories Microbiology Specimen Volume
U.K.
Public Health Laboratories Microbiology Specimen Volume
U.K.
Commercial/Private Laboratories Microbiology Specimen Volume
U.K.
Microbiology Test Volume by Market Segment
U.K.
Microbiology Test Volume by Application
U.K.
Microbial Identification Test Volume by Market Segment
U.K.
Urine Screening Test Volume by Market Segment
U.K.
Antibiotic Susceptibility Test Volume by Market Segment
U.K.
Blood Culture Test Volume by Market Segment
U.K.
Microbiology Consumables Market by Application
U.K.
Microbiology Consumables Market by Market Segment
U.K.
Microbial Identification Consumables Sales by Market Segment
U.K.
Antibiotic Susceptibility Consumables Sales by Market Segment
U.K.
Blood Culture Consumables Sales by Market Segment
U.K.
Urine Screening Consumables Sales by Market Segment
U.K.
All Market Segments Infectious Disease Test Volume Forecast by Assay
U.K.
All Market Segments Infectious Disease Diagnostics Market Forecast by Test
U.K.
Infectious Disease Blood Screening NAT Volume Forecast by Assay
U.K.
Infectious Disease Blood Screening NAT Reagent Market Forecast by Assay
U.K.
HIV/AIDS Testing Market Diagnostics Sales by Major Supplier
U.K.
HIV/Hepatitis Blood Screening NAT Market Diagnostics Sales
by Major Supplier
U.K.
Campylobacter Testing Market Diagnostics Sales by Major Supplier
U.K.
Candida Testing Market Diagnostics Sales by Major Supplier
U.K.
Gonorrhea Testing Market Diagnostics Sales by Major Supplier
U.K.
Hepatitis Testing Market Diagnostics Sales by Major Supplier
U.K.
Hepatitis C Testing Market Diagnostics Sales by Major Supplier
U.K.
Influenza Testing Market Diagnostics Sales by Major Supplier
U.K.
Mycoplasma Testing Market Diagnostics Sales by Major Supplier
U.K.
Pneumonia Testing Market Diagnostics Sales by Major Supplier
U.K.
RSV Testing Market Diagnostics Sales by Major Supplier
U.K.
Rubella Testing Market Diagnostics Sales by Major Supplier
U.K.
Septicemia Testing Market Diagnostics Sales by Major Supplier
U.K.
Shigella Testing Market Diagnostics Sales by Major Supplier
U.K.
Streptococci Testing Market Diagnostics Sales by Major Supplier
U.K.
Syphilis Testing Market Diagnostics Sales by Major Supplier
U.K.
Tuberculosis Testing Market Diagnostics Sales by Major Supplier
U.K.
Molecular Diagnostics Market Sales and Shares of Major Suppliers
II. Automated Microbiology Market Business Environment
III. New Product Development Opportunities
IV. Design Criteria for Decentralized Testing Products
V. Alternative Market Penetration Strategies
VI. Potential Market Entry Barriers and Risks
VII. Market and Technology Overview
A. Introduction
1. Major Factors Affecting Market Penetration for Microbiology Instrumentation
2. Traditional Practices
3. Technological Challenges
4. Automation: Impact on the Microbiology Laboratory and the Patient
B. Major Specimen Types
1. Urine
2. Sterile Fluids: Blood, Serum, and CSF
3. Throat Swabs and Respiratory Secretions
4. Genital Secretions
5. Stool
6. Abscess/Wound
7. Sputum
8. Saliva
C. Test Applications
1. Microbial Identification
2. Antibiotic Susceptibility
3. Urine Screening
a. Photometry
b. Bioluminescence
c. Colorimetric Filtration
d. Enzymatic Detection
e. Optical Detection
4. Blood Cultures
Table of Contents
(continued)
D. Major Automated and Semi-automated Microbiology Systems
1. Multiple Purpose Microbiology Systems
2. Specialized Microbiology Systems
3. Molecular Diagnostic Systems
4. Immunodiagnostic Systems
E. Emerging Diagnostic Technologies
1. Molecular Diagnostics (Amplification Methods, Sequencing, Microarrays/Biochips)
a. DNA Sequencing
b. DNA and RNA Probe Technologies
c. Detection Technologies
d. Biochips: Genosensors, Microarrays, Labs-on-the-Chip
2. Monoclonal Antibodies
3. Immunoassays
4. Differential Light Scattering
5. Information Technology
6. Artificial Intelligence
7. Liposomes
8. Flow Cytometry
9. Chromatography
10. Diagnostic Imaging
11. Gel Microdroplets
12. Other
VIII. Country Analysis
A. Business Environment
B. Market Structure
C. Market Size, Growth and Major Supplier Sales and Market Shares
IX. Competitive
Assessments
- Abbott Laboratories
- Agilent Technologies
- Beckman Coulter/Danaher
- bioMerieux
- Bio-Rad
- DiaSorin
- Eiken Chemical
- Fujifilm Wako
- Fujirebio
- Grifols
- Instrumentation Laboratory/Werfen
- Kyowa Medex
- OrthoQuidel
- PerkinElmer
- Quest Diagnostics
- Roche
- Siemens Healthineers
- Sysmex
- Thermo Fisher
- Tosoh
List Of Tables
Major Companies Developing or Marketing AIDS TestsMajor Companies Developing or Marketing Adenovirus Tests
Major Companies Developing or Marketing Bartonella Tests
Major Companies Developing or Marketing Campylobacter Tests
Major Companies Developing or Marketing Candida Tests
Major Companies Developing or Marketing Chlamydia Tests
Major Companies Developing or Marketing Clostridium Tests
Major Companies Developing or Marketing Coronavirus Tests
Major Companies Developing or Marketing Cryptosporidium Tests
Major Companies Developing or Marketing CMV Tests
Major Companies Developing or Marketing Echovirus Tests
Major Companies Developing or Marketing Enterovirus Tests
Major Companies Developing or Marketing EBV Tests
Major Companies Developing or Marketing Giardia Tests
Major Companies Developing or Marketing Gonorrhea Tests
Major Companies Developing or Marketing Hantavirus Tests
Major Companies Developing or Marketing Helicobacter Pylori Tests
Major Companies Developing or Marketing Hepatitis Tests
Major Companies Developing or Marketing Herpes Tests
Major Companies Developing or Marketing Influenza Tests
Major Companies Developing or Marketing Legionella Tests
Major Companies Developing or Marketing Lyme Disease Tests
Major Companies Developing or Marketing Lymphogranuloma Tests
Major Companies Developing or Marketing Malaria Tests
Major Companies Developing or Marketing Measles Tests
Major Companies Developing or Marketing Meningitis Tests
Major Companies Developing or Marketing Microsporidium Tests
Major Companies Developing or Marketing Mononucleosis Tests
Major Companies Developing or Marketing Mumps Tests
Major Companies Developing or Marketing Mycoplasma Tests
Major Companies Developing or Marketing Papilloma Virus Tests
Major Companies Developing or Marketing Parvovirus Tests
Major Companies Developing or Marketing Pneumonia Tests
Major Companies Developing or Marketing RSV Tests
Major Companies Developing or Marketing Rotavirus Tests
Major Companies Developing or Marketing Rubella Tests
Major Companies Developing or Marketing Salmonella Tests
Major Companies Developing or Marketing Septicemia Tests
Major Companies Developing or Marketing Shigella Tests
Major Companies Developing or Marketing Staphylococci Tests
Major Companies Developing or Marketing Streptococci Tests
Major Companies Developing or Marketing Syphilis Tests
Major Companies Developing or Marketing Toxoplasmosis Tests
Major Companies Developing or Marketing Trichomonas Tests
Major Companies Developing or Marketing Tuberculosis Tests
Major Companies Developing or Marketing West Nile Tests
Major Companies Developing or Marketing Yersinia Tests
U.K.
Laboratories Performing Microbiology Tests by Market Segment
U.K.
Hospital Laboratories Performing Microbiology Tests by Bed Size
U.K.
Commercial/Private Laboratories Performing Microbiology Tests
by Annual Test Volume
U.K.
All Market Segments Microbiology Specimen Volume
U.K.
Hospital Laboratories Microbiology Specimen Volume
U.K.
Public Health Laboratories Microbiology Specimen Volume
U.K.
Commercial/Private Laboratories Microbiology Specimen Volume
U.K.
Microbiology Test Volume by Market Segment
U.K.
Microbiology Test Volume by Application
U.K.
Microbial Identification Test Volume by Market Segment
U.K.
Urine Screening Test Volume by Market Segment
U.K.
Antibiotic Susceptibility Test Volume by Market Segment
U.K.
Blood Culture Test Volume by Market Segment
U.K.
Microbiology Consumables Market by Application
U.K.
Microbiology Consumables Market by Market Segment
U.K.
Microbial Identification Consumables Sales by Market Segment
U.K.
Antibiotic Susceptibility Consumables Sales by Market Segment
U.K.
Blood Culture Consumables Sales by Market Segment
U.K.
Urine Screening Consumables Sales by Market Segment
U.K.
All Market Segments Infectious Disease Test Volume Forecast by Assay
U.K.
All Market Segments Infectious Disease Diagnostics Market Forecast by Test
U.K.
Infectious Disease Blood Screening NAT Volume Forecast by Assay
U.K.
Infectious Disease Blood Screening NAT Reagent Market Forecast by Assay
U.K.
HIV/AIDS Testing Market Diagnostics Sales by Major Supplier
U.K.
HIV/Hepatitis Blood Screening NAT Market Diagnostics Sales
by Major Supplier
U.K.
Campylobacter Testing Market Diagnostics Sales by Major Supplier
U.K.
Candida Testing Market Diagnostics Sales by Major Supplier
U.K.
Gonorrhea Testing Market Diagnostics Sales by Major Supplier
U.K.
Hepatitis Testing Market Diagnostics Sales by Major Supplier
U.K.
Hepatitis C Testing Market Diagnostics Sales by Major Supplier
U.K.
Influenza Testing Market Diagnostics Sales by Major Supplier
U.K.
Mycoplasma Testing Market Diagnostics Sales by Major Supplier
U.K.
Pneumonia Testing Market Diagnostics Sales by Major Supplier
U.K.
RSV Testing Market Diagnostics Sales by Major Supplier
U.K.
Rubella Testing Market Diagnostics Sales by Major Supplier
U.K.
Septicemia Testing Market Diagnostics Sales by Major Supplier
U.K.
Shigella Testing Market Diagnostics Sales by Major Supplier
U.K.
Streptococci Testing Market Diagnostics Sales by Major Supplier
U.K.
Syphilis Testing Market Diagnostics Sales by Major Supplier
U.K.
Tuberculosis Testing Market Diagnostics Sales by Major Supplier
U.K.
Molecular Diagnostics Market Sales and Shares of Major Suppliers
RELATED REPORTS
U.S Infectious Disease Testing Market Shares
2024 U.S. Infectious Disease Testing Market Shares-Competitive Analysis of Leading and Emerging Market Players This new report provides infectious diseases testing market shares.The report analyses current and emerging suppliers of
View ReportU.S Infectious Disease Testing Market Shares
2024 U.S. Infectious Disease Testing Market Shares-Competitive Analysis of Leading and Emerging Market Players This new report provides infectious diseases testing market shares.The report analyses current and emerging suppliers of
View Report2024 Ukraine Coagulation Testing Market
2024 Ukraine Coagulation Testing Market--Hemostasis Analyzers and Consumables--2023 Supplier Shares, 2023-2028 Segment Volume and Sales Forecasts for over 40 Coagulation Assays, Opportunities for Suppliers--Molecular, Chromogenic and Immunodiagnostic Hemostasis Tests--Growth Strategies,
View Report2024 Ukraine Immunoassay Analyzers and Reagents Supplier Shares
2024 Ukraine Immunoassay Analyzers and Reagents--2023 Supplier Shares and Competitive Analysis, 2023-2028 Volume and Sales Segment Forecasts for 100 Abused Drugs, Cancer Diagnostic, Endocrine Function, Immunoproteins, TDMs, and Special Chemistry
View ReportSAMPLE REQUEST
Fill The Form For Sample Request
REVIEWS
